Search
Compliance-ready comprehensive solutions for GLP-1 analysis
Accurate GLP-1 analysis requires sensitive, reliable, and compliance-ready analytical workflows. Thermo Fisher Scientific delivers advanced analytical solutions for GLP-1 characterization, DMPK and QC release testing, supporting laboratories with high-performance chromatography, LC-MS analysis, and compliance-ready software. These integrated solutions help streamline workflows, maintain data integrity, and support regulatory expectations across development and routine quality control.
Structural and impurity characterization of GLP-1 therapeutics
Robust characterization of GLP-1 therapeutics requires high-resolution separation, hight resolution accurate mass analysis, and advanced data interpretation. Thermo Fisher Scientific solutions support detailed structural and impurity characterization using high-performance LC, HRAM mass spectrometry, specialized peptide columns, and dedicated biopharmaceutical data analysis software to deliver confidence from early development through late-stage studies.
Comprehensive peptide characterization workflow for GLP-1 development
Separation |
Separation |
MS analysis |
Data processing |
Metabolite and degradation product identification
Accurate metabolite and degradation product identification is critical to understanding GLP-1 safety and stability profiles. Comprehensive LC-HRAM MS workflows with intelligent data acquisition and fragmentation strategies enable sensitive, confident identification of known and unknown species, supporting compliance-ready metabolite identification studies.
Identification of GLP-1–related metabolites and degradation products workflow
Separation |
MS analysis |
MS analysis |
Data processing |
Quantitative bioanalysis of GLP-1 therapeutics
Reliable bioanalysis of GLP-1 therapeutics demands high sensitivity, robustness, and data integrity. Thermo Fisher Scientific bioanalytical solutions support quantitative LC-MS workflows with compliance-ready data acquisition, processing, and laboratory informatics to help meet regulatory expectations in regulated environments.
Sensitive and reproducible bioanalytical workflows for GLP-1 quantification
Separation |
MS analysis |
Data processing |
Data processing |
Routine QC and release testing for GLP-1 products
Routine QC release testing of GLP-1 drug substances and products requires consistent performance and reproducible separation of related impurities. High-performance LC systems, UV detection, validated peptide columns, and compliance-ready chromatography software, ensures final drug quality and purity, essential for safety, efficacy and meeting regulation demands.
Reliable, stability-indicating workflows for routine GLP-1 quality control
Separation |
Separation |
Detection |
Data processing |
The LC-MS are not intended for in vitro diagnostic purposes in accordance with our product documentation, manuals, and labels. They are designated for General Laboratory Use Only.
Our Products have not been tested or validated for such applications and their use for in vitro diagnostic purposes may result in inaccurate results and, more seriously, health and safety risks. They are designated for Research Use Only Applications.